promise over the years, none of them is yet clinically acceptable due to the uncertainty about their beneficial effects [5] . Consequently, there is an unmet need for treatment options for HI brain injury that address oxidativestress-induced HI damage along with other effects such as inflammation, cell death, and repair.
Erythropoietin (Epo) is a hematopoietic cytokine with an established role in neuroprotection. Although it is primarily produced in the kidneys and liver, studies also show the expression of Epo receptor and Epo production in the brain early in development [6, 7] . Epo production is evident primarily in astrocytes (Ast) [8] , and to a lesser extent in neurons [9] and oligodendrocytes [8, 10] , where it occurs in a regulated manner. All these cells, along with microglia (Mg) [11] , also express Epo receptor and see an upregulation after injury [12] , suggesting that Epo has a role in postinjury processes in the brain. Indeed, several lines of evidence, both in vivo and in vitro, have now established that Epo has important neuroprotective, neurogenic, angiogenic, and oligodendrogliogenic properties after HI [10, 13, 14] . Promising clinical trials with Epo as a potential treatment for preterm and term brain injury are currently underway [15] .
Despite its promise as a potential treatment for HI injury, there are currently limited data on the specific effects of Epo on oxidative and inflammatory responses after HI injury, especially in glial cells. While some evidence suggests that Epo has antiapoptotic, antioxidative, and antiinflammatory effects on Ast and Mg [16] , few reports exist of posttreatment with Epo, and even fewer report Epo effects after a direct oxidative insult on these cells. Moreover, closer analysis of the literature suggests that Epo can have differential effects on different cell types [16] , highlighting the importance of understanding the timing and pattern of these responses in determining effective dosing strategies for clinical trials.
The aim of this study was to characterize the oxidative and inflammatory responses of Ast and Mg to exogenous Epo following an oxidative insult utilizing H 2 O 2 exposure as the model of oxidative stress injury in vitro. We have previously shown that H 2 O 2 levels in the immature (but not adult) brain are sustained at high levels after injury for at least 5 days [17] , rendering it highly susceptible to oxidative injury over a prolonged period. In order to mimic this in vitro, we utilized an enzymatic system where we used glucose oxidase and catalase to generate and break down (respectively) H 2 O 2 and maintain it at a constant level [18, 19] . We have previously shown that this system can be successfully used in vitro on Mg to induce oxidative and inflammatory responses [18] . Here, we extend this analysis to cultured Ast, examine the responses after treatment with Epo, and show that Epo has differential, pleiotropic effects on Mg and Ast.
Experimental Procedures

Materials
The following reagents were all sourced from the Cell Culture Facility at the University of California San Francisco, CA, USA: Hanks' balanced salt solution, Dulbecco's modified Eagle's medium (DMEM; phenol red-free, 4.5 g/L glucose, with no pyruvate), penicillin-streptomycin (P/S), fetal bovine serum (FBS; Axenia Biologix), and 0.05% trypsin. Glucose oxidase (GOX, G0543), catalase (CAT, C3155), H 2 O 2 (H1009), and H2DCFDA (#D6883) were from Sigma (St. Louis, MO, USA). Neurobasal (NB) medium (12348-017), B27 (17504044), B27 without antioxidants (10889038), GlutaMax I (35050), Griess reagent (G7921), Live-Dead Assay (L3224), and the LDH cytotoxicity kit (11644793001) were from Roche. Recombinant murine (rm)Epo (959-ME-010) was from R&D Systems (reconstituted in 0.1% BSA PBS).
Mg and Ast Cultures and H 2 O 2 Treatment
Animals were sacrificed in accordance with guidelines from the Institutional Animal Care and Use Committee at the University of California San Francisco, CA, USA. Mixed glial cultures were prepared from P1 C57BL/6 mice (Simonsen Laboratories, Gilroy, CA, USA). Their brains were isolated, stripped of meninges, mechanically dissociated, and trypsinized for 15 min at 37 ° C. Following resuspension in DMEM supplemented with 1% P/S and 10% FBS, cells were seeded (2 brains/T-75 flask) and then incubated at 37 ° C/5% CO 2 . Medium was changed the next day and then every 3 days subsequently. After 10-14 days, the flasks containing mixed glial cultures were shaken for 1-2 h at 200 rpm and 37 ° C to lift off the microglial cells, which were then plated into 24-well plates in DMEM supplemented with 1% P/S and 2% FBS overnight and used the next day. Cells from a 75-cm 2 flask were seeded into a 24-well plate. Ast contamination in Mg cultures was confirmed to be <5% using immunofluorescence (Iba-1 for Mg, glial fibrillary acid protein for Ast, and O 4 for oligodendrocyte labeling; data not shown).
Following Mg isolation, the flasks were replenished with fresh DMEM supplemented with 1% P/S and 10% FBS, sealed with Parafilm, and shaken for 24 h. The medium was replaced again, and the flasks resealed and shaken for another 24 h until no phase-dark cells (oligo-dendroglia) were visible. Ast were then trypsinized with 0.05% trypsin, pelleted, and plated into 24-well plates at a density of 250,000 cells/well overnight and used the next day. The Mg contamination of Ast cultures was established to be <5% as confirmed by immunocytochemistry (Iba-1 for Mg, glial fibrillary acid protein for Ast, and O 4 for oligodendrocyte labeling; data not shown).
Mg and Ast Stimulation with H 2 O 2 and Treatment with rmEPO
The GOX-CAT method is an enzymatic method that can be used to generate low, continuous H 2 O 2 for over 24 h [18, 19] . GOX is a stable enzyme that remains fully active over 24 h at 37 24 -well plates using a GOX activity of 1: 100,000 and a medium volume of 0.5 mL [19] .
The aims of the experiments were to study the responses of these cell types to low and high continuous exposures of H 2 O 2 . The low and high doses for each of the cell types was determined from titration studies where the dose eliciting minimal, i.e., ≤ 2-fold of control cell death, was considered a low dose, and that 2-to 4-fold of control cell death was equated as a high dose, as measured at 24 h after exposure. In all experiments, GOX was kept at a constant dilution of 1: 100,000, whereas CAT dilution varied (1: 20, treatments were carried out in serum-free DMEM (DMEM SF) with 1% P/S. DMEM SF served as a control for the H 2 O 2 treatments. Following overnight plating in 2% FBS DMEM, the medium in the plates was replaced with prewarmed test medium (containing GOX-CAT/ control) for 4 h. At 4 h, rmEpo was added into the medium at a final concentration of 10 ng/mL in DMEM SF (a volume of 10 μL), with the dose chosen based on previously published data showing this to be an effective dose for eliciting cellular effects [20, 21] ; 10 μL DMEM SF was added into the non-Epo control wells at the same time.
All assays were run in duplicate and repeated independently 6 times. Experiments were ended 20 h later (24 h from the start of H 2 O 2 treatment). For pretreatment studies, cells were exposed to 10 ng/mL Epo for 24 h prior to H 2 O 2 exposure for 2 h.
In vitro Assays
All in vitro assays were carried out at the end of the study (24 h from the start of H 2 O 2 treatment and 20 h from Epo addition), unless otherwise stated.
Viability Assay Mg and Ast viability in response to H 2 O 2 treatment were assessed using the LDH assay according to the manufacturer's instructions. LDH release into the medium was compared to total LDH in the medium following cell lysis. For pretreatment studies, LDH release was measured at the end of 2 h of H 2 O 2 exposure.
Nitrite Assay Nitrite levels in medium were used as a surrogate measure of nitric oxide (NO) using the Griess reagent according to the manufacturer's protocols. Briefly, at the end of the designated time period, 150 μL of medium from each well was mixed with 20 μL of Griess reagent and 130 μL of deionized water for 30 min at room temperature. Absorbance was measured and expressed relative to the reference (sodium nitrite) sample at 548 n M after normalizing to the amount of protein in the well.
Reactive Oxygen Species Assay Cellular reactive oxygen species (ROS) content was measured using the H2DCFDA reagent. At the end of the designated time period, cells were loaded with 20 μ M H2DCFDA for 45 min at 37 ° C. Following 2 washes with prewarmed Hanks' balanced salt solution, fluorescence absorption was measured at 485 ex /535 em nm. Results were normalized to the amount of protein in the well.
Mitochondrial Superoxide Assay
Mitochondrial superoxide levels were measured using MitoSOX Red indicator dye. As it is readily oxidized by superoxide but not by other ROS-/reactive nitrogen species-generating systems, it would give an accurate measure of superoxide levels in response to H 2 O 2 treatment. At the end of the time period, cells were loaded with 5 μ M Mito-SOX dye in prewarmed DMEM SF for 10 min at 37 ° C. Following 2 washes in the same medium, fluorescence absorption was measured at 485 ex /590 em nm, and results were normalized to the amount of protein in the well.
Multiplex Assay for Cytokine Measurements
Cytokine protein expression in Mg-/Ast-conditioned medium was assessed according to the manufacturer's instructions on a custom mouse 15-plex cytokine MicroBead assay kit which allows for the simultaneous detection of 15 inflammatory molecules in a single 75-μL sample including KC, MCP-1, MIP-1α, MIP-1β, MIP-2, RANTES, G-CSF, IL-1a, IL-1b, IL-4, IL-6, IL-9, IL-10, IL-13, and TNFα. Results were analyzed using a Bio-Plex workstation (Bio-Rad), and then levels were normalized to the total amount of protein in the appropriate well and subsequently expressed as fold of control. For discussion purposes, KC, MCP-1, MIP-1α, MIP-1β, MIP-2, and RANTES were loosely categorized as chemokines, with the remainder classified as cytokines. Protein concentrations were determined using the Bio-Rad DC protein assay. Data are expressed as picograms per microgram of protein. The level of sensitivity for each MicroBead cytokine standard curve ranged from 1 to 35 pg/mL. Two 96-well assays were performed in duplicate, with each plate containing Mg-/Ast-conditioned medium from 6 independent experiments. For neuron-conditioned medium (NCM) studies, medium from 3 independent experiments was assessed.
Primary Cortical Neuronal Culture and Generation of NCM
Cultures were prepared from the cortices of embryonic day 15 C57BL/6 mice as previously described [22] . Briefly, embryos were harvested from the dam under terminal anesthesia, and the cortices were isolated, papain digested, and plated onto PDL-pre-coated 24-well plates in NB medium. On day 3 in vitro (DIV3), AraC was added to a final concentration of 5 μ M , and on DIV4, half of the medium was exchanged for fresh NB medium with B27-antioxidants. Experiments were initiated on DIV6 when medium was replaced with fresh NB medium with B27-antioxidants containing 50 μ M H 2 O 2 (or just NB-antioxidants for control) for 30 min. At the end of 20 min, the NCM was collected and centrifuged at 5,000 rpm for 5 min at 4°C before storage at -80°C until use. On the day of use, NCM was thawed on ice and concentrated using 3,000-Da molecular-weight cut-off filters (UFC800324, Millipore). 50 μL of concentrated and microglia (Mg) were exposed to continuous H 2 O 2 for 4 h before treatment with 10 ng/mL rmEpo. LDH release into the medium was measured after 20 h of Epo treatment (24 h after the start of H 2 O 2 injury). Mg ( a ) and Ast ( b ) LDH release. Pretreament (1 h) with 10 ng/mL Epo before administering H 2 O 2 for 2 h elicited protection in Ast ( d ) but not in Mg ( c ). Results are a composite of at least 6 (posttreatment) and 3 (pretreatment) independent assays. * p < 0.05, * * p < 0.01, ** * p < 0.0001 versus control.
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NCM was added per well to the Ast or Mg culture, at the same time as H 2 O 2 .
Statistics
All statistical analyses were performed using GraphPad Prism v5.0 (La Jolla, CA, USA). Wilcoxon signedrank tests were used to compare treatments with and without rmEpo and to control on data normalized to the protein content for each respective treatment well. All results are expressed as means ± SEM and significance was accepted at p ≤ 0.05.
Results
Viability
Epo has been shown to be protective in a range of experimental paradigms. Here, we tested the neuroprotective capacity of rmEpo following H 2 O 2 injury in primary Mg and Ast using LDH release as a measure.
As expected, H 2 O 2 exposure induced significant cell death at the higher concentrations for both cell types ( p < 0.0001; Fig. 1 a-d) . The addition of 10 ng/mL rmEpo following a 4-h H 2 O 2 -induced injury did not appear to be protective in either cell type ( Fig. 1 a-d) , but when pretreated for 24 h with rmEpo, protection was seen in Ast ( p < 0.05; Fig. 1 f) but not in Mg ( Fig. 1 e) .
Oxidative Stress Nitrites The effects of Epo on NO production/nitrite levels in cultured cells vary and appear to be largely due to factors like which type of cell or stimulus is involved [16] . We tested whether rmEpo would alter nitrite levels in cultured Mg and Ast stimulated with H 2 O 2 .
There were no significant changes in nitrite levels in Mg with either H 2 O 2 or rmEpo treatment ( Fig. 2 a) . In Ast, however, nitrite levels were considerably suppressed after H 2 O 2 ( Fig. 2 b) , and following rmEpo treatment, they were significantly increased ( Fig. 2 b , p < 0.05 and p < 0.01, respectively, for low and high continuous H 2 O 2 ).
Reactive Oxidative Species Epo has been widely reported to have antioxidative properties. However, most in vitro studies utilize a pretreatment paradigm. The aim of our study was to evaluate the posttreatment effects of rmEpo on the intracellular levels of ROS.
In Mg, low-dose H 2 O 2 significantly increased ROS levels, and rmEpo treatment significantly suppressed the fluorescence of high continuous H 2 O 2 cultures ( Fig. 2 c; p < 0.05) but had no effect on low H 2 O 2 cultures. In Ast, there were no significant changes in ROS levels with either H 2 O 2 or rmEpo treatment ( Fig. 2 d) .
Superoxide
While no significant changes were seen with H 2 O 2 treatment in Mg, rmEpo led to significant suppression of indicator levels in high continuous H 2 O 2 cultures ( Fig. 2 e; p < 0.05). In Ast cultures, no significant changes in Mito-SOX indicator levels were seen with either H 2 O 2 or rmEpo treatment ( Fig. 2 f) .
Inflammatory Responses
Both Mg and Ast mediate neuroinflammation via cytokine and chemokine release. We analyzed the cytokine and chemokine secretion profile for both Mg and Ast following rmEpo treatment of H 2 O 2 -induced injury.
Overall, significant changes were evident in chemokine levels in Mg. Low H 2 O 2 caused an increase in the levels of MIP-2 and RANTES ( p < 0.05; Fig. 3 g, h) , with a similar trend but failing to reach significance in TNFα and MIP-1α ( p = 0.06; Fig. 3 a, c) . High continuous H 2 O 2 suppressed MIP-1α, MIP-1β, and RANTES ( p < 0.05; Fig. 3 c, e, h ). rmEpo treatment did not have any significant effects. There were no significant changes in any inflammatory mediator levels in Ast ( Fig. 4 ) .
Neuron-Conditioned Medium
Since cytokine/chemokine responses to H 2 O 2 did not seem to be significantly altered by rmEpo in most of the paradigms tested, we speculated that the presence of at least signaling molecules from injured neurons might be necessary for glial cells to elicit significant secretory responses. To this end, we exposed cortical neurons to 30 min of 50 μ M H 2 O 2 , and transferred this NCM to Mg and Ast at the same time as H 2 O 2 was added. Results are shown only for cytokines/chemokines exhibiting considerable changes.
Overall, there were no significant changes with the addition of NCM along with H 2 O 2 , nor were there any significant effects of rmEpo on chemokine/cytokine levels in either cell type ( Fig. 5 , Mg; Fig. 6 , Ast). There was, however, a notable nonsignificant increase in secretion in the NCM wells that was suppressed in the presence of 50 μ M H 2 O 2 .
Discussion
Although there has been much interest in using Epo as a protective and restorative agent after injury to the central nervous system, the response of Ast and Mg to Epo after oxidative stress is largely unknown. Here, we found differential effects in these cell types in terms of viability, oxidative responses, and inflammatory mediator secretion, both without and with the presence of NCM.
Viability
In the conditions tested in this study, rmEpo did not significantly reduce H 2 O 2 -induced cell death in either cell type when given 4 h after H 2 O 2 initiation, even at high H 2 O 2 levels. There are studies that have shown protection of Mg with Epo posttreatment up to 6 h after the insult, but they differ in terms of the type of injury as well as species [21, 23] , which suggests that Epo-mediated protection in Mg depends on such factors [20, 21, 23] . In Ast, on the other hand, while there was a trend towards a decrease in cell death after high H 2 O 2 , this failed to reach significance.
In support of previous reports [24] , pretreatment reduced LDH release in Ast, but failed to show any effect on Mg LDH release, which contrasts with previous reports [21, 25] . While it is possible that the cells were injured 2 . rmEpo effects on NO, ROS, and superoxide levels following H 2 O 2 injury. Cultured primary murine astrocytes (Ast) and microglia (Mg) were exposed to continuous or bolus H 2 O 2 for 4 h before treatment with 10 ng/mL rmEpo. Secreted NO levels ( a , b ) in the medium were measured using the Griess assay, ROS levels ( c , d ) were measured using the H2DCFDA indicator, and superoxide levels ( e , f ) were measured using the MitoSOX indicator at the end of the study. H 2 O 2 did not have any significant effects on secreted nitrite levels in either Mg ( a ) or Ast ( b ), but Epo significantly increased the NO levels in the Ast wells. There was significant suppression of microglial ROS and superoxide with Epo treatment at the high continuous dose in Mg ( c , e ) but not in Ast ( d , f ) . The results presented here are compiled from at least 5 independent assays run in duplicate. * p < 0.05, * * p < 0.01 versus control.
beyond the possibility of repair at the higher concentrations, it is more likely that rmEpo mediates protection primarily in Ast rather than in Mg after H 2 O 2 injury. Support for this hypothesis comes from several findings that suggest Epo has pleiotropic effects, depending on cell and injury type [16] . For example, Epo activates the p38-MAPK pathway in Ast to preserve their integrity [26, 27] , but blocking this pathway in vivo does not affect neuronal survival [28] . Moreover, while it has been identified that Akt1-dependent Epo signaling maintains endothelial cell [29] and Mg [21, 25] integrity, it does not appear to play a role in Ast neuroprotection [30] .
Oxidative Stress
While H 2 O 2 can induce cell death in the neonatal brain via the apoptotic death cascade [31] , it is known especially for eliciting damaging effects via its reaction with excess free iron (Fenton reaction), leading to the generation of free radicals such as the hydroxyl radical, superoxide, and NO, all of which lead to subsequent damage [17, 32] . Although there is some evidence that Epo leads to a decrease in NO levels in Mg [23, 33] , most studies have shown that it has no significant effect on NO production in activated Mg cultures [23, [31] [32] [33] [34] . Here, we actually saw an increase in nitrite levels with Epo treatment in both Mg and Ast (only significant in Ast). Wenker et al. [35] , reported increased nitrite production in Mg after Epo exposure of a microglial cell line, an effect that was lost when an inhibitor of the PI3K pathway was used; a similar mode of action might have been relevant in our study. Other studies have reported a similar Epo-mediated increase in NO and NO synthase levels in various tissues [36, 37] . An increase in NO in endothelial cells is thought to maintain blood pressure homeostasis and blood flow [38] , and NO induced in the central nervous system via HIF 1α -mediated Epo production has been shown to prevent axonal degeneration [39] . It is possible that the increase in NO is actually a beneficial manifestation of Epo signaling following oxidative stress. The increase in NO levels with rmEpo treatment was observed only in the cultures exposed to continuous H 2 O 2 in Ast. Glial cells have been shown to have a high antioxidative capacity [40, 41] that renders them highly tolerant to oxidative stress and capable of effectively disposing of oxidants such as H 2 O 2 within a short time [42, 43] , which makes sustained H 2 O 2 production application more relevant for studies such as ours. The sustained H 2 O 2 better mimics the in vivo situation following neonatal HI insult [17] . Studying the effects of Epo treatment during such an insult yields a much better understanding of the mechanisms of Epo activity.
Both ROS and MitoSOX levels were suppressed with rmEpo treatment in continuous H 2 O 2 -exposed Mg, highlighting an antioxidative role for rmEpo that other studies reported previously [44] . There was, however, no significant change in the ROS levels in Ast, supporting sugges- tions that Epo appears to act via various mechanisms depending on the individual cell and injury types [16] . This finding is in contradiction to that reported by Liu et al. [45] , who showed an amelioration of MitoSOX indicator levels with Epo treatment following paraquat-induced oxidative stress in Ast. It is likely that the difference between the 2 studies regarding the type of injury accounts for these disparate findings [46] . Inflammation rmEpo treatment failed to elicit any significant effects on the levels of secreted cytokines and chemokines in both cell types. Low continuous H 2 O 2 elicited the maximal statistically significant responses in chemokine levels (MIP-2 and RANTES) in Mg, as we reported previously with similar nonsignificant effects in Ast for the same chemokines (MIP-1α, MIP-1β, MIP-2, and RANTES) as well as for KC and G-CSF [18] . This reflects previous findings that H 2 O 2 , acting as a second messenger, induces chemokine responses [47, 48] . Chemokine expression is an important mediator of the proliferation, recruitment, and migration of Mg, as well as of other immune and stem cells which provide for the containment and resolution of injury [49] [50] [51] . It appears that low continuous H 2 O 2 , which we presume is functioning as a signaling molecule, acts to provide preconditioning protection [52] . In addition to the above chemokine responses, Ast also had disparate responses to certain cytokines such as G-CSF, IL-6, and IL-4, which were unresponsive in Mg. This discrepancy in inflammatory responses is an indication of the variation in responses of both cell types to injury. For example, a previous study showed that endotoxin stimulated Mg to produce 95 times more TNFα than did Ast [53] . Ultimately, there was no apparent antior proinflammatory effect for either cell type in response to H 2 O 2 , or, more importantly, to Epo. While the lack of an anti-inflammatory effect for Epo in Mg has already been widely established [23, 33, 34] , to our knowledge, this is the first study to report cytokine/chemokine secretion by Ast in response to Epo treatment following H 2 O 2 injury. This suggests that Epo-mediated neuroprotection is a result of mechanisms other than those directly mediating inflammation, at least in the paradigms tested in this study.
While the presence of NCM augmented the levels of chemokines (MIP-1α, MIP-1β, and RANTES) secreted in the microglial cells, the presence of H 2 O 2 appeared to dampen this augmentation. This is somewhat surprising, considering that H 2 O 2 has been established as a chemokine-inducing factor [47] . The fact that the presence of NCM itself was sufficient to elicit this increase, regardless of whether it was from uninjured or injured neurons, points to the importance of cell-to-cell signaling in the brain, i.e., that Mg secretory responses are enhanced in the presence of neuronal communication (not significant with the Wilcoxon test). Chong et al. [25] showed that there was an increase in Mg proliferation and phosphatidyl serine receptor expression in response to NCM from injured neurons, a phenomenon that could be blocked by Epo pretreatment. In our study, rmEpo treatment did not appear to have any significant effect on Mg exposed to NCM, suggesting that (1) pretreatment with rmEpo would be more effective or (2) rmEpo does not modulate cytokine/chemokine responses in Mg.
A similar dampening of NCM-augmented secretory responses was evident in Ast treated with H 2 O 2 , although on a much lower scale, suggesting that the mechanisms involved were similar to those in Mg, despite Mg being much more responsive to NCM than Ast. The addition of NCM suppressed MIP-2 and TNFα levels considerably, suggesting that the presence of neurons dampens H 2 O 2 -induced MIP-2 and TNFα levels. Both MIP-2 and TNFα have been shown to be produced in response to injury [54] , with deleterious effects. Modulation of their secreted levels in the presence of NCM suggests that neuronal communication is an important factor controlling their secretion, potentially ameliorating a harmful response.
In conclusion, it appears that rmEpo-mediated cellular effects are pleiotropic and multifaceted, depending not only on the cell type but also on the mode and level of injury and treatment. In terms of the oxidative and secretory responses of Mg and Ast, rmEpo appears to have largely similar effects on both cell types, some of which are significantly different to those reported in the neurons. Ultimately, this study highlights the importance of taking into careful consideration multiple necessary factors, which, cohesively, could predict the optimal use of Epo following injury.
